Ligand id: 7986

Name: rilotumumab

Compound class Antibody
International Nonproprietary Names
INN number INN
9123 rilotumumab
AMG 102 | AMG102
Rilotumumab is a monoclonal antibody directed against hepatocyte growth factor (HGF), developed as a treatment for solid tumours.
Annotated peptide sequences for this antibody are available from its IMGT/mAb-DB record. Peptide sequence BLAST search using the heavy and light chain variable regions of rilotumumab provides 100% matches to sequences covered by patent US8609090 [1], and to the antibody with designation 2.12.1.
Database Links
Specialist databases
IMGT/mAb-DB 302
Other databases
GtoPdb PubChem SID 249565667
Search PubMed clinical trials rilotumumab
Search PubMed titles rilotumumab
Search PubMed titles/abstracts rilotumumab
Wikipedia Rilotumumab